A hard choice

by Anthony Mills January 1, 2004

written by Anthony Mills January 1, 2004

Viagra users in Lebanon will this month be presented with a choice: to continue using Viagra, whose impotence-combating effects last for a few hours, or to switch to Cialis, which lasts for a whopping 36. Cialis, a new anti-impotence drug produced by biotech firm Icos and marketed by US pharmaceutics powerhouse Eli Lilly

Anthony Mills

M. Anthony Mills is a senior fellow at the American Enterprise Institute and the Pepperdine School of Public Policy, as well as a scholar associate of the Society of Catholic Scientists. Previously, he served as associate editor of The New Atlantis, executive editor of Big Questions Online, and was a journalist at Executive magazine in Lebanon. Mills holds a Ph.D. in philosophy from the University of Notre Dame and writes extensively on topics related to science and philosophy.

Sign up for our newsletter

and join us in the pursuit of reliable

and pertinent analysis

A hard choice

You may also like

Sign up for our newsletter

and join us in the pursuit of reliable

and pertinent analysis